Company Overview of Edison Pharmaceuticals, Inc.
Edison Pharmaceuticals, Inc. develops medicines for the treatment of mitochondrial diseases and neurological diseases. It focuses on the science of cellular energy and the development of drugs targeting for the control of metabolism. Edison Pharmaceuticals, Inc. has a strategic alliance with Dainippon Sumitomo Pharma Co., Ltd. The company was founded in 2005 and is based in Mountain View, California with additional offices in the Netherlands. Edison Pharmaceuticals, Inc. operates as a subsidiary of Galileo Pharmaceuticals, Inc.
350 North Bernardo Avenue
Mountain View, CA 94043
Founded in 2005
Key Executives for Edison Pharmaceuticals, Inc.
Edison Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Edison Pharmaceuticals, Inc., please visit www.edisonpharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.